Antonella Cordoba/LinkedIn
Aug 9, 2026, 15:16
Antonella Cordoba: Emicizumab and the Evolving Landscape of Hemophilia A
Antonella Cordoba, Médica Hematologa at Hospital General de Agudos José Maria Penna, shared a post on LinkedIn:
”The meeting organized by Roche on Hemlibra (emicizumab) and the new advances in the treatment of hemophilia A was very enriching.
A space for updating and exchange on how innovation continues to transform the approach to hemorrhagic diseases.
Thank you Guillermo Rabossi for the invitation and for generating these learning spaces.”
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions